Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.970
+0.270 (10.00%)
At close: Jul 16, 2025, 4:00 PM
2.860
-0.110 (-3.70%)
After-hours: Jul 16, 2025, 6:24 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $111.89 million as of July 16, 2025. Its market cap has decreased by -40.10% in one year.
Market Cap
111.89M
Enterprise Value
-11.16M
1-Year Change
-40.10%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $111.89M, a decrease of -77.08%. That is a compound annual growth rate of -30.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 101.72M | -63.00% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.83B |
| Johnson & Johnson | 373.35B |
| AbbVie | 329.24B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 264.62B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 217.99B |